NIRAPARIB FOR NEWLY DIAGNOSED GLIOBLASTOMA
A Phase 0 clinical trial to evaluate niraparib, a novel targeted therapy, in patients with newly diagnosed glioblastoma.
Talk to an Ivy Navigator
602-406-8605Talk to an Ivy Navigator
602-406-8605A Phase 0 clinical trial to evaluate niraparib, a novel targeted therapy, in patients with newly diagnosed glioblastoma.